ArticleThe oncologist2013

Health care costs and resource utilization, including patient burden, associated with novel-agent-based treatment versus other therapies for multiple myeloma: findings using real-world claims data.

April Teitelbaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.